Mechanism
Activin A
Assets acting on this target.
- Class
- Activin A-neutralizing monoclonal antibody
- Notes
- hand ruling, audit finding #2468; OVERRIDE: the source states garetosmab neutralises the activin A LIGAND and does not target the receptor, so this is the receptor/ligand distinction being applied rather than violated; source: https://clinicaltrials.gov/api/v2/studies/NCT07559513